Treatment against hemorrhagic transformation after delayed tPA treatment that targets vascular remodeling factors
-
- Shimohata Takayoshi
- Department of Neurology, Brain Research Institute, Niigata University
-
- Kanazawa Masato
- Department of Neurology, Brain Research Institute, Niigata University
-
- Takahashi Tetsuya
- Department of Neurology, Brain Research Institute, Niigata University
-
- Nishizawa Masatoyo
- Department of Neurology, Brain Research Institute, Niigata University
Bibliographic Information
- Other Title
-
- 血管リモデリング因子を標的としたtPA 療法後脳出血合併症の治療
Search this article
Description
We investigated the possibility that vascular instability associated with vascular remodeling is one of the causes of hemorrhagic transformation that occurs after delayed tissue plasminogen activator (tPA) treatment against ischemic stroke. Using a rat thromboembolic model, we determined the changes of vascular remodeling factors, such as vascular endothelial growth factor (VEGF) and angiopoietin-1 (Ang1), and found (i) the activation of VEGF-VEGF receptor signaling pathway and (ii) decrease in Ang1 expression in the peri-ischemic regions at 24 hours after ischemia. We also found that the hemorrhagic transformation was suppressed by (i) the inhibition of VEGF-VEGF receptor signaling pathway that used an anti-VEGF neutralizing antibody or a VEGF receptor inhibitor and (ii) supplemental treatment using a recombinant Ang1 protein. These findings suggest that therapeutic intervention that targets vascular remodeling factors may be a therapeutic strategy for inhibiting hemorrhagic transformation after delayed tPA treatment.
Journal
-
- Japanese Journal of Stroke
-
Japanese Journal of Stroke 37 (3), 188-193, 2015
The Japan Stroke Society
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679616484992
-
- NII Article ID
- 130005072677
-
- ISSN
- 18831923
- 09120726
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed